MedPath

Investigation of the Efficacies of a Resveratrol Formula on Improvement of Skin Conditions and Inflammatory Related Factors

Not Applicable
Completed
Conditions
Skin Conditions
Proinflammatory Cytokines
Registration Number
NCT04456829
Lead Sponsor
TCI Co., Ltd.
Brief Summary

To assess a resveratrol formula on improvement of skin conditions and inflammatory cytokines in blood

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Healthy volunteers aged above 20 years old
Exclusion Criteria
  • Subject who is not willing to participate in this study.
  • Patients with diseases of the skin, heart, liver, kidney, endocrine and other organs and patients with mental illness (according to medical history).
  • Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder.
  • Female who is pregnant or nursing or planning to become pregnant during the course of the study.
  • Received facial laser therapy, chemical peeling or UV overexposure in the past 4 weeks.
  • Subjects who have large spots (area >3 square centimeter) or abnormal acne.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The change of IL-17 of blood0 and 8 weeks

ELISA Kit

The change of skin collagen density0, 4, and 8 weeks

DermaLab® USB - 20 MHz High Freq. Ultrasound probe was utilized to scan and analyze skin collagen density. Units:

Intensity score

The change of TNF-alpha of blood0 and 8 weeks

ELISA Kit

The change of skin moisture0, 4, and 8 weeks

Corneometer® CM825 was utilized to measure skin moisture. Units: arbitrary Corneometer® units 0-120

The change of skin elasticity0, 4, and 8 weeks

Cutometer® dual MPA 580 was utilized to measure skin elasticity (parameter R2). Units: μm penetration depth into the probe opening, expressed as curves

The change of skin wrinkles0, 4, and 8 weeks

VISIA Complexion Analysis System was utilized to measure wrinkles. Units: arbitrary units

The change of skin texture0, 4, and 8 weeks

VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units

The change of total antioxidant capacity of blood0 and 8 weeks

Total Antioxidant Capacity Assay Kit

The change of skin pores0, 4, and 8 weeks

VISIA Complexion Analysis System was utilized to measure skin pores. Units: arbitrary units

The change of IL-6 of blood0 and 8 weeks

ELISA Kit

The change of IL-1β of blood0 and 8 weeks

ELISA Kit

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chia Nan University of Pharmacy & Science

🇨🇳

Tainan City, Taiwan

Chia Nan University of Pharmacy & Science
🇨🇳Tainan City, Taiwan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.